JCR Pharmaceuticals Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JCR Pharmaceuticals Co., Ltd. with three other
pharmaceutical manufacturers in Asia:
Kyongbo Pharmaceutical Co Ltd
of South Korea
sales of 201.34 billion Korean Won [US$176.98 million]
of which 100%
was Drugs & Pharmaceutical Raw Materials),
Industri Jamu dan Farmasi Sido Muncul Tbk PT
(2.76 trillion Indonesian Rupiahs [US$196.19 million]
of which 67%
was Herbal medicine), and
Tibet Cheezheng Tibetan Medicine Co Ltd
based in China
(1.19 billion Chinese Renmimbi [US$177.25 million]
JCR Pharmaceuticals Co., Ltd. reported sales of ¥20.59 billion (US$183.90 million)
March of 2018.
increase of 13.9%
versus 2017, when the company's sales were ¥18.09 billion.
Sales at JCR Pharmaceuticals Co., Ltd. have increased during each of the previous five years
(and since 2013, sales have increased a total of 46%).
Sales of Pharmaceutical Business saw an increase
14.1% in 2018, from
¥17.68 billion to ¥20.18 billion.